Aurobindo Pharma jumps 5% on reports of USFDA clearing Unit-4 facility By Admin on March 13, 2019 Shares of Aurobindo Pharma opened at Rs 752.90 on BSE against its previous closing of Rs 748.80. Original source: https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-jumps-5-on-reports-of-usfda-clearing-unit-4-facility/68371095?utm_source=RSS&utm_medium=ETRSS Also Read: Strides develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment Published in Industry News Health NewsPharma ArticlesPharma News Admin More from Industry NewsMore posts in Industry News »Zydus cuts price of generic remdesivirFrench pharma firm guilty of fraud, manslaughter over weight loss pill: courtEquity indices swing higher, metal and pharma stocks gainFrench pharma giant faces verdict on weight loss pill deaths